EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 95 filers reported holding EPIZYME INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -96.6% | 1,015 | -96.0% | 0.00% | – |
| Q1 2022 | $29,000 | -73.1% | 25,410 | -41.2% | 0.00% | – |
| Q4 2021 | $108,000 | +10700.0% | 43,246 | +36241.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 119 | -10.5% | 0.00% | – |
| Q2 2021 | $1,000 | -98.6% | 133 | -98.4% | 0.00% | – |
| Q1 2021 | $73,000 | -90.4% | 8,363 | -88.0% | 0.00% | – |
| Q4 2020 | $758,000 | +42.2% | 69,780 | +56.2% | 0.00% | – |
| Q3 2020 | $533,000 | -46.5% | 44,661 | -28.0% | 0.00% | – |
| Q2 2020 | $997,000 | +52.4% | 62,066 | +47.3% | 0.00% | – |
| Q1 2020 | $654,000 | -36.5% | 42,138 | +0.6% | 0.00% | – |
| Q4 2019 | $1,030,000 | -37.3% | 41,868 | -73.7% | 0.00% | – |
| Q3 2019 | $1,643,000 | +37.0% | 159,266 | +40.7% | 0.00% | – |
| Q2 2019 | $1,199,000 | +24.5% | 113,222 | +45.7% | 0.00% | – |
| Q1 2019 | $963,000 | +266.2% | 77,714 | +82.0% | 0.00% | – |
| Q4 2018 | $263,000 | -23.1% | 42,693 | +32.3% | 0.00% | – |
| Q3 2018 | $342,000 | -16.8% | 32,261 | +6.4% | 0.00% | – |
| Q2 2018 | $411,000 | -33.9% | 30,328 | -13.5% | 0.00% | – |
| Q1 2018 | $622,000 | +83.5% | 35,074 | +29.9% | 0.00% | – |
| Q4 2017 | $339,000 | -51.2% | 27,002 | -26.0% | 0.00% | – |
| Q3 2017 | $695,000 | +47.9% | 36,473 | +17.3% | 0.00% | – |
| Q2 2017 | $470,000 | -11.8% | 31,097 | 0.0% | 0.00% | – |
| Q1 2017 | $533,000 | +36.7% | 31,097 | -3.7% | 0.00% | – |
| Q4 2016 | $390,000 | +214.5% | 32,283 | +156.0% | 0.00% | – |
| Q3 2016 | $124,000 | -4.6% | 12,613 | -0.8% | 0.00% | – |
| Q2 2016 | $130,000 | -28.2% | 12,713 | -15.2% | 0.00% | – |
| Q1 2016 | $181,000 | +23.1% | 14,983 | +63.8% | 0.00% | – |
| Q4 2015 | $147,000 | +14.0% | 9,147 | -8.6% | 0.00% | – |
| Q3 2015 | $129,000 | -14.6% | 10,008 | +58.6% | 0.00% | – |
| Q2 2015 | $151,000 | +60.6% | 6,312 | +25.1% | 0.00% | – |
| Q1 2015 | $94,000 | +754.5% | 5,046 | +749.5% | 0.00% | – |
| Q4 2014 | $11,000 | -31.2% | 594 | +1.0% | 0.00% | – |
| Q3 2014 | $16,000 | -42.9% | 588 | -35.9% | 0.00% | – |
| Q2 2014 | $28,000 | +600.0% | 917 | +358.5% | 0.00% | – |
| Q4 2013 | $4,000 | – | 200 | +3233.3% | 0.00% | – |
| Q3 2013 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |